» Articles » PMID: 9469334

Life After Breast Cancer: Understanding Women's Health-related Quality of Life and Sexual Functioning

Overview
Journal J Clin Oncol
Specialty Oncology
Date 1998 Feb 20
PMID 9469334
Citations 242
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To describe the health-related quality of life (HRQL), partner relationships, sexual functioning, and body image concerns of breast cancer survivors (BCS) in relation to age, menopausal status, and type of cancer treatment.

Patients And Methods: A cross-sectional sample of BCS in two large metropolitan areas was invited to participate in a survey study that included the following standardized measures: the RAND 36-Item Health Survey; the Centers for Epidemiologic Studies-Depression Scale (CES-D); the Dyadic Adjustment Scale (DAS); the Breast Cancer Prevention Trial (BCPT) Symptom Checklist; the Watts Sexual Functioning Questionnaire (WSFQ); and subscales from the Cancer Rehabilitation Evaluation System (CARES).

Results: Eight hundred sixty-four BCS completed the survey. RAND Health Survey scores were as good or better than those of healthy, age-matched women, and the frequency of depression was similar to general population samples. Marital/partner adjustment was similar to normal healthy samples, and sexual functioning mirrored that of healthy, age-matched postmenopausal women. However, these BCS reported higher rates of physical symptoms (eg, joint pains, headaches, and hot flashes) than healthy women. Sexual dysfunction occurred more frequently in women who had received chemotherapy (all ages), and in younger women who were no longer menstruating. In women > or = 50 years, tamoxifen therapy was unrelated to sexual functioning.

Conclusion: BCS report more frequent physical and menopausal symptoms than healthy women, yet report HRQL and sexual functioning comparable to that of healthy, age-matched women. Nevertheless, some survivors still experience poorer functioning, and clinicians should inquire about common symptoms to provide symptomatic management or counseling for these women.

Citing Articles

Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial.

Faltinova M, Vehmanen L, Lyytinen H, Savolainen-Peltonen H, Virtanen A, Haanpaa M Breast Cancer Res Treat. 2024; .

PMID: 39729211 DOI: 10.1007/s10549-024-07564-8.


Latent Profile Analysis and Determinants of Marital Adjustment in Patients with Breast Cancer.

Chen X, Shen C, Gu Z, Dong C, Zhuang Y, Lu L J Multidiscip Healthc. 2024; 17:5799-5809.

PMID: 39655292 PMC: 11627107. DOI: 10.2147/JMDH.S494987.


Efficacy of a couple-based intervention addressing sexual concerns for breast cancer survivors: Results of a randomized controlled trial.

Reese J, Lepore S, Sorice K, Zimmaro L, Hasler J, Handorf E Cancer. 2024; 131(1):e35685.

PMID: 39645589 PMC: 11696781. DOI: 10.1002/cncr.35685.


Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy: an ASTRRA Substudy.

Lee Y, Noh W, Gwark S, Kim H, Ryu J, Kim S Breast Cancer Res. 2024; 26(1):152.

PMID: 39501399 PMC: 11539666. DOI: 10.1186/s13058-024-01903-9.


Machine Learning-Based Predictive Model for Mortality in Female Breast Cancer Patients Considering Lifestyle Factors.

Zhen M, Chen H, Lu Q, Li H, Yan H, Wang L Cancer Manag Res. 2024; 16:1253-1265.

PMID: 39297055 PMC: 11410026. DOI: 10.2147/CMAR.S460811.